- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- October 2023
- 140 Pages
North America
From €4228EUR$4,400USD£3,614GBP
- Report
- April 2019
- 153 Pages
Global
From €1321EUR$1,375USD£1,130GBP
€2642EUR$2,750USD£2,259GBP
- Report
- February 2021
- 90 Pages
Global
€21139EUR$22,000USD£18,072GBP
- Report
- April 2023
- 181 Pages
Global
From €2402EUR$2,500USD£2,054GBP
- Report
- July 2021
- 115 Pages
Global
From €3200EUR$3,568USD£2,832GBP
- Book
- March 2020
- 281 Pages
- Book
- December 2022
- 1376 Pages
- Book
- April 2020
- 342 Pages
Nephropathy is a medical condition that affects the kidneys and is a major focus of Urology and Nephrology. It is caused by a variety of factors, including diabetes, hypertension, and glomerulonephritis. Symptoms of nephropathy can include proteinuria, edema, and hypertension. Treatment options vary depending on the cause and severity of the condition, but may include medications, lifestyle changes, and dialysis.
The nephropathy market is a rapidly growing sector of the Urology and Nephrology industry. It is driven by the increasing prevalence of chronic kidney diseases, as well as the development of new treatments and technologies. Companies in this market are focused on developing and marketing products and services to diagnose, treat, and manage nephropathy. Examples of companies in this market include Baxter International, Fresenius Medical Care, and DaVita. Show Less Read more